Type of PKD1 mutation influences renal outcome in ADPKD.
about
Recommendations for the use of tolvaptan in autosomal dominant polycystic kidney disease: a position statement on behalf of the ERA-EDTA Working Groups on Inherited Kidney Disorders and European Renal Best PracticeMacrophage Migration Inhibitory Factor in Clinical Kidney DiseaseA polycystin-centric view of cyst formation and disease: the polycystins revisitedARPKD and early manifestations of ADPKD: the original polycystic kidney disease and phenocopiesPolycystin-1: a master regulator of intersecting cystic pathwaysSpanish guidelines for the management of autosomal dominant polycystic kidney diseaseIdentification of MMP1 as a novel risk factor for intracranial aneurysms in ADPKD using iPSC models.Screening for Unruptured Intracranial Aneurysms in Autosomal Dominant Polycystic Kidney Disease: A Survey of 420 NephrologistsIdentification of people with autosomal dominant polycystic kidney disease using routine data: a cross sectional study.Genetic mechanisms and signaling pathways in autosomal dominant polycystic kidney disease.Temporal and geographical external validation study and extension of the Mayo Clinic prediction model to predict eGFR in the younger population of Swiss ADPKD patients.Novel functional complexity of polycystin-1 by GPS cleavage in vivo: role in polycystic kidney diseaseImaging classification of autosomal dominant polycystic kidney disease: a simple model for selecting patients for clinical trials.Predictors of autosomal dominant polycystic kidney disease progressionPolycystic kidney disease: Kidney volume--a crystal ball for ADPKD prognosis?Diagnosis of autosomal dominant polycystic kidney disease using efficient PKD1 and PKD2 targeted next-generation sequencingAutosomal-dominant polycystic kidney disease (ADPKD): executive summary from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference.Mutations in GANAB, Encoding the Glucosidase IIα Subunit, Cause Autosomal-Dominant Polycystic Kidney and Liver DiseaseRenal replacement therapy in ADPKD patients: a 25-year survey based on the Catalan registry.Molecular analysis of a consanguineous Iranian polycystic kidney disease family identifies a PKD2 mutation that aids diagnostics.Imaging-based diagnosis of autosomal dominant polycystic kidney disease.Clinical characteristics and disease predictors of a large Chinese cohort of patients with autosomal dominant polycystic kidney diseaseNovel mutations of PKD genes in the Czech population with autosomal dominant polycystic kidney disease.Altered trafficking and stability of polycystins underlie polycystic kidney disease.Polycystin-1 maturation requires polycystin-2 in a dose-dependent manner.A novel PKD1 variant demonstrates a disease-modifying role in trans with a truncating PKD1 mutation in patients with autosomal dominant polycystic kidney disease.Aquaporin-1 retards renal cyst development in polycystic kidney disease by inhibition of Wnt signaling.Identification of novel PKD1 and PKD2 mutations in Korean patients with autosomal dominant polycystic kidney diseaseAutosomal dominant polycystic kidney disease in children.Identification of Biomarkers for PKD1 Using Urinary Exosomes.The Future of Polycystic Kidney Disease Research--As Seen By the 12 Kaplan Awardees.Whole-genome sequencing overcomes pseudogene homology to diagnose autosomal dominant polycystic kidney diseaseAnthropometric and Metabolic Risk Factors for ESRD Are Disease-Specific: Results from a Large Population-Based Cohort Study in Austria.Assessing Risk of Disease Progression and Pharmacological Management of Autosomal Dominant Polycystic Kidney Disease: A Canadian Expert Consensus.Identification of novel PKD1 and PKD2 mutations in a Chinese population with autosomal dominant polycystic kidney diseaseMutational analysis of PKD1 gene in a Chinese family with autosomal dominant polycystic kidney diseaseLRP5 variants may contribute to ADPKDComprehensive PKD1 and PKD2 Mutation Analysis in Prenatal Autosomal Dominant Polycystic Kidney Disease.The PROPKD Score: A New Algorithm to Predict Renal Survival in Autosomal Dominant Polycystic Kidney Disease.mTORC1-mediated inhibition of polycystin-1 expression drives renal cyst formation in tuberous sclerosis complex.
P2860
Q26767011-4A25EE4E-A5EC-46E9-8DE9-2F059AF08F39Q26767479-5C890E8D-1927-47F0-82FE-8ECD6AD585DDQ26800974-FA16375C-338B-40A0-AC34-E75F8AD0CE66Q26824716-5EE5FB85-C56B-41EB-A4C4-7877881CB7D2Q26826955-07C68EB6-F321-4A4A-ADEC-663B0463BD2FQ26863397-ED6D87BF-0472-47DB-9162-699B18AD13C3Q27324613-76A06DDD-DB8A-4F32-ACEE-69E9A298F6CDQ28601031-5DCF459F-2CA8-43CC-80D3-781290BDF87DQ30870783-0A46AC4A-2ACB-4A0A-A2EE-78F813C9A93AQ33872509-73154233-C350-4A47-9828-5C9B9C0CC6F4Q33910788-E90580C2-4858-40B7-9856-46D7726DBF0FQ34056378-BA7E7F99-5097-4A0C-BEB5-536D8BC47076Q34423262-9630FC2C-B520-4DC8-85CB-E823A1415D57Q34427678-36D87F63-AE0D-4D5E-B864-1EBE9C5CE752Q34432301-D5131786-0E11-4CD0-AE88-C1D5534255C4Q34444336-33FF9508-EBE9-40B1-9E45-6CEC10B39179Q34467747-88690920-7602-4FC1-ACB3-8CB6848890BDQ34529587-6F8319E6-C279-40BF-97E6-2FB5E4FD4BD7Q34978995-36885CDF-6278-428C-ACF0-E740814408A0Q34980440-2FF3FF66-69E6-4B28-B0DD-B588A084FF6DQ35124261-6E05F57F-92BB-495E-91B8-8E4C810E483DQ35126716-FCA1ED35-4D54-4F64-ABA6-B9426C8B27B9Q35138042-D47D39F0-BF57-4F2A-857C-3E3368EBD50BQ35145360-DB7948B2-CB5E-4341-97EA-4E834382BEA5Q35149861-D8E7EBC9-F2BB-44F2-AC96-912A497AA45FQ35170215-1CA9554F-97B3-4B50-B0BF-F96040BD8C03Q35410778-A618EE67-D4D7-4261-9EFC-7BDC4101906DQ35505201-6FD19B76-529E-4A18-9450-8BA74B072444Q35596375-4A327906-FA09-442B-931D-021D04857A69Q35790549-68CF47A0-B2E5-4450-B547-4CF9AC2B2018Q36003176-2BD1F7F5-0AC4-48B6-A2A2-F95EAF42D58AQ36013634-1578A26E-8525-46DB-BFB4-0EE780870B88Q36106884-E8803D92-16BE-49FB-977C-371AD247F3EEQ36315686-7EE5D189-6BE9-490F-9280-A89F4BA01F5FQ36343363-45CEE8ED-D772-42C9-B328-A5CF10D65511Q36375427-C567EF5A-9DD9-4778-8CF2-D23EE375AA49Q36475048-46BB8FF6-6D62-4CF2-9FDF-59DA179D499DQ36624649-D9A8D024-71EE-4453-AF15-DF233876602DQ36624712-698F0EEA-887C-4C6F-8080-8DE2AA7A5574Q36651027-5B6B756B-1CDA-45D0-95AA-3EF6C300F07A
P2860
Type of PKD1 mutation influences renal outcome in ADPKD.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Type of PKD1 mutation influences renal outcome in ADPKD.
@en
type
label
Type of PKD1 mutation influences renal outcome in ADPKD.
@en
prefLabel
Type of PKD1 mutation influences renal outcome in ADPKD.
@en
P2093
P2860
P356
P1476
Type of PKD1 mutation influences renal outcome in ADPKD.
@en
P2093
Anne Grall-Jezequel
Bassem Whebe
Christophe Charasse
Claude Férec
Emilie Cornec-Le Gall
Eric Renaudineau
Jian-Min Chen
Marie-Pascale Morin
Marie-Paule Guillodo
Marie-Pierre Audrézet
P2860
P304
P356
10.1681/ASN.2012070650
P577
2013-02-21T00:00:00Z